PEPT (Regenerex Pharma) Beta : N/A (As of Sep. 21, 2024)

Regenerex Pharma Beta Chart

Regenerex Pharma Annual Data
	Trend	Nov10	Nov11	Nov12	Nov13	Nov14	Mar17	Mar18	Mar22	Mar23	Mar24
Beta		Get a 7-Day Free Trial					-	-	-	-	-

Regenerex Pharma Quarterly Data
	Nov14	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Beta	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Regenerex Pharma's Beta

For the Medical Instruments & Supplies subindustry, Regenerex Pharma's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerex Pharma's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Regenerex Pharma's Beta distribution charts can be found below:

* The bar in red indicates where Regenerex Pharma's Beta falls into.

Regenerex Pharma Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Regenerex Pharma  (OTCPK:PEPT) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Regenerex Pharma Beta Related Terms

Thank you for viewing the detailed overview of Regenerex Pharma's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerex Pharma Business Description